Analystreport

Erytech Pharma SA (NASDAQ: ERYP) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.

Erytech Pharma S.A. - American Depositary Shares  (ERYP) 
US:NASDAQ Investor Relations: investors.erytech.com